Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 388.49% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 110.72% | -- | -- | -- | |
| Operating Income | -110.72% | -- | -- | -- | |
| Income Before Tax | -65.50% | -- | -- | -- | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -65.50% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -65.50% | -- | -- | -- | |
| EBIT | -110.72% | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 33.08% | -- | -- | -- | |
| Normalized Basic EPS | 22.43% | -- | -- | -- | |
| EPS Diluted | 32.82% | -- | -- | -- | |
| Normalized Diluted EPS | 22.43% | -- | -- | -- | |
| Average Basic Shares Outstanding | 140.15% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 140.15% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |